3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
2
Completed
2
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pneumonia
1
Lung Neoplasms
1
Lung Injury
1
Hypoxia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
132
Cisplatin
129
Pemetrexed
114
Docetaxel
81
Drug Therapy
62
Gefitinib
57
anlotinib
55
Gemcitabine
55
Erlotinib Hydrochloride
55
Radiotherapy
48
Bevacizumab
48
pembrolizumab
47
Paclitaxel
47
Etoposide
44
apatinib
42
icotinib
41
camrelizumab
39
osimertinib
36
Nivolumab
33
Vinorelbine
31
Radiosurgery
30
sintilimab
29
durvalumab
25
aumolertinib
25
endostar protein
24
atezolizumab
22
Endostatins
22
toripalimab
19
Blood Specimen Collection
19
tislelizumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Thoracotomy
×
Thoracic
×
Clear all
NCT04755478
2021-02-16
OPEN THORUS
Hospital General Universitario de Valencia
Unknown
30 enrolled
NCT02360761
2016-09-20
STEPS
Peking University People's Hospital
Phase 3
Unknown
339 enrolled